Shuttle Pharmaceuticals (NASDAQ: SHPH) took center stage at the Planet MicroCap Showcase: VEGAS 2025 on April 23, offering investors and…
Read More »Shuttle Pharmaceuticals
Biotech can be brutal, but when a tiny stock with a tight float and a powerful narrative starts to run,…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH) is advancing its mission to revolutionize prostate cancer treatment. On April 10, 2025, the company announced…
Read More »
As President Trump’s sweeping tariffs and immigration policies continue to weigh on financial markets, many investors have taken a step…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH), a specialty pharmaceutical company dedicated to enhancing radiation therapy outcomes for cancer patients, reported the closing…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH), a specialty pharmaceutical company dedicated to enhancing radiation therapy outcomes for cancer patients, has taken two…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH) has filed its Annual Report on Form 10-K for the fiscal year ending December 31, 2024,…
Read More »
Radiation therapy is a cornerstone of cancer treatment, with approximately 50% of cancer patients undergoing it during their illness. A…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH), a discovery and development-stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its stock price…
Read More »